A detailed history of Hickory Point Bank & Trust transactions in Eli Lilly & CO stock. As of the latest transaction made, Hickory Point Bank & Trust holds 261 shares of LLY stock, worth $163,294. This represents 0.16% of its overall portfolio holdings.

Number of Shares
261
Previous 256 1.95%
Holding current value
$163,294
Previous $211 Million 3.77%
% of portfolio
0.16%
Previous 0.19%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 08, 2025

BUY
$713.71 - $898.95 $3,568 - $4,494
5 Added 1.95%
261 $203 Million
Q1 2025

Apr 14, 2025

BUY
$725.72 - $929.72 $185,784 - $238,008
256 New
256 $211 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $594B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hickory Point Bank & Trust Portfolio

Follow Hickory Point Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hickory Point Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Hickory Point Bank & Trust with notifications on news.